Burn patients needed for antibiotic dosing study
NCT ID NCT07465432
First seen Mar 20, 2026 · Last updated Apr 28, 2026 · Updated 8 times
Summary
This study looks at how the antibiotic cefiderocol works in people with severe burns. The goal is to find the best dose to kill bacteria and prevent resistance. Researchers will study 12 adults to see how the drug moves through the body after a burn injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG CLEARANCE AFTER SEVERE BURN INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regional One Health
RECRUITINGMemphis, Tennessee, 38103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.